A Clinical Study Comparing Rituximab and Cladribine for Relapsing Multiple Sclerosis
Norwegian study of Oral cladribine versus Rituximab in Multiple Sclerosis (NOR-MS). A prospective randomized open-label blinded endpoint (PROBE) multicenter non-inferiority study. - NOR-MS Norwegian study of Oral cladribine versus Rituximab in Multiple Sclerosis (NOR-MS). A prospective ra ...
Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital
NULL
Authorised-recruitment may be ongoing or finished
Female: yes Male: yes
264
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): yes Therapeutic use (Phase 4): no Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...